Search Results - Maria Giuseppa Vitale
- Showing 1 - 11 results of 11
-
1
-
2
Pembrolizumab in Vaginal Carcinoma: A Case Report and Review of the Literature by Maria Giuseppa Vitale, Cecilia Nasso, Beatrice Riccò, Alessandro Bocconi, Chiara Chiavelli, Cinzia Baldessari, Stefania Pipitone, Francesca Bacchelli, Laura Botticelli, Massimo Dominici, Roberto Sabbatini
Published in Case Reports in Oncology (2024-04-01)Get full text
Article -
3
ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy by Maria Giuseppa Vitale, Carmela Barbato, Anna Crispo, Francesco Habetswallner, Bernardo Maria De Martino, Ferdinando Riccardi, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Giacomo Cartenì
Published in Molecules (2020-05-01)Get full text
Article -
4
Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers by Ilenia Mastrolia, Virginia Catani, Marco Oltrecolli, Stefania Pipitone, Maria Giuseppa Vitale, Valentina Masciale, Chiara Chiavelli, Carlo Augusto Bortolotti, Cecilia Nasso, Giulia Grisendi, Roberto Sabbatini, Massimo Dominici
Published in Biology (2023-06-01)Get full text
Article -
5
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especia... by Maria Giuseppa Vitale, Anna Crispo, Dario Arundine, Riccardo Ronga, Carmela Barbato, Assunta Luongo, Francesco Habetswallner, Bernardo Maria De Martino, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Ferdinando Riccardi
Published in Frontiers in Pharmacology (2022-11-01)Get full text
Article -
6
A Novel Molecular Profile of Hormone‐Sensitive Prostate Cancer Defines High Risk Patients by Claudia Piombino, Cecilia Nasso, Stefania Bettelli, Samantha Manfredini, Maria Giuseppa Vitale, Stefania Pipitone, Cinzia Baldessari, Matteo Costantini, Albino Eccher, Ilenia Mastrolia, Virginia Catani, Francesca Bacchelli, Stefania Ferretti, Massimo Dominici, Roberto Sabbatini
Published in Cancer Medicine (2025-02-01)Get full text
Article -
7
Cerebellar metastasis of ovarian cancer: a case report by Eleonora Cabitza, Marta Pirola, Cinzia Baldessari, Giuditta Bernardelli, Elena Zunarelli, Stefania Pipitone, Maria Giuseppa Vitale, Cecilia Nasso, Eleonora Molinaro, Marco Oltrecolli, Elisa D’Agostino, Vincenzo Dario Mandato, Andrea Palicelli, Massimo Dominici, Roberto Sabbatini
Published in Journal of Medical Case Reports (2023-12-01)Get full text
Article -
8
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients by Sebastiano Buti, Alessandro Olivari, Cristina Masini, Davide Bimbatti, Donata Sartori, Paola Ermacora, Carlo Cattrini, Maria Giuseppa Vitale, Ernesto Rossi, Claudia Mucciarini, Mimma Rizzo, Michele Sisani, Matteo Santoni, Giandomenico Roviello, Veronica Mollica, Vincenza Conteduca, Francesco Grillone, Marika Cinausero, Giuseppe Prati, Francesco Atzori, Marco Stellato, Francesco Massari, Melissa Bersanelli
Published in Therapeutic Advances in Urology (2024-04-01)Get full text
Article -
9
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) by Matteo Santoni, Giandomenico Roviello, Enrique Grande, Ugo De Giorgi, Ondrej Fiala, Emmanuel Seront, Javier Molina-Cerrillo, Renate Pichler, Zin W. Myint, Jakub Kucharz, Ravindran Kanesvaran, Thomas Büttner, Martin Pichler, Umberto Basso, Jindrich Kopecky, Maria T. Bourlon, Linda Cerbone, Tomas Buchler, Alvaro Pinto, Alfonso Gómez de Liaño, Caterina Gianni, Anca Zgura, Pasquale Rescigno, Jawaher Ansari, Orazio Caffo, Zsófia Küronya, Maria Giuseppa Vitale, Dipen Bhuva, Martina Catalano, Nuno Vau, Ray Manneh Kopp, Sebastiano Buti, Aristotelis Bamias, Camillo Porta, Kaisa Sunela, Francesco Massari
Published in Cancer Immunology, Immunotherapy (2025-05-01)Get full text
Article -
10
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study by Mimma Rizzo, Andrey Soares, Enrique Grande, Aristotelis Bamias, Ray Manneh Kopp, Edoardo Lenci, Thomas Buttner, Samer Salah, Francesco Grillone, Icaro Thiago de Carvalho, Jose Carlos Tapia, Calogero Gucciardino, Alvaro Pinto, Alessia Mennitto, Halima Abahssain, Pasquale Rescigno, Zin Myint, Hideki Takeshita, Gian Paolo Spinelli, Lazar Popovic, Maria Giuseppa Vitale, Ondrej Fiala, Patrizia Giannatempo, Roubini Zakopoulou, Francesco Carrozza, Francesco Massari, Fernando Sabino Marques Monteiro, Maria Paola Pace, Massimo Giannini, Giandomenico Roviello, Camillo Porta, Nicola Battelli, Ravindran Kanesvaran, Matteo Santoni
Published in Scientific Reports (2024-08-01)Get full text
Article -
11
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice by Alessandro Russo, Paolo Antonio Ascierto, Alessio Cortellini, Daniele Santini, Raffaele Giusti, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Marco Russano, Cecilia Anesi, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Maria Giuseppa Vitale, Francesca Rastelli, Rita Chiari, Alain Gelibter, Giampiero Porzio, Corrado Ficorella, Domenico Mallardo, Sergio Bracarda, Claudia Bareggi, Maria Grazia Vitale, Alessandro Inno, Olga Nigro, Vincenzo Adamo, Laura Pala, Alessandro Tuzi, Enrica Teresa Tanda, Marco Tucci, Luigia Stefania Stucci, Francesco Spagnolo, Renato Bisonni, Linda Nicolardi, Nicola Petragnani, Serena Macrini, Barbara Di Cocco, David James Pinato
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article
